This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Shane Kovacs Receives The 2014 New Jersey Technology Council CFO - Deal Of The Year Award

SOUTH PLAINFIELD, N.J., June 13, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Shane Kovacs, Chief Financial Officer, has received the 2014 Deal of the Year Award from the New Jersey Technology Council (NJTC). The Deal of the Year Award is part of the annual NJTC CFO Awards Breakfast, which recognizes the accomplishments of financial executives from the region's diverse technology community.

PTC Therapeutics logo

"I am honored to receive the CFO – Deal of the Year Award. When I joined PTC last year, we had just closed on a successful private placement and were about to kick-off what would also prove to be a very successful IPO. The combination of PTC's novel science, late-stage assets, a promising pipeline and a focus on rare and neglected disorders drew strong interest from institutional investors for both our IPO and our subsequent follow-on equity offering," said Shane Kovacs, Chief Financial Officer of PTC Therapeutics, Inc. "The combined capital we raised will allow PTC to continue to advance the clinical development of our pipeline candidates and to prepare for the anticipated launch of Translarna for the treatment of Duchenne muscular dystrophy across Europe. I am excited to be a part of the PTC team at such a transformational time in the history of the company."

"We are very proud for Shane to be recognized as an accomplished CFO. He joined the company a year ago and has been a valuable addition to the team. His broad depth of experience gives him the ability to work cross-functionally at PTC and help shape the strategic direction of our company," stated Stuart Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics, Inc. "Shane's expertise will be influential as PTC prepares to launch its first drug in Europe and build-out a commercial organization."

Prior to joining PTC, Mr. Kovacs served as Managing Director, Health Care Investment Banking at Credit Suisse. In this capacity, he focused on advising life science companies on transactions ranging from equity and debt financings to mergers and acquisitions.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs